Ditchcarbon
  • Contact
  1. Organizations
  2. PharmaJet, Inc.
Public Profile
Medical Device Manufacturing
US
updated a month ago

PharmaJet, Inc. Sustainability Profile

Company website

PharmaJet, Inc., headquartered in the United States, is a pioneering company in the biopharmaceutical industry, specialising in needle-free injection technology. Founded in 2009, PharmaJet has made significant strides in enhancing vaccine delivery systems, particularly in regions where traditional methods may pose challenges. The company’s core product, the PharmaJet Stratis® device, offers a unique, efficient, and pain-free method for administering vaccines, making it particularly valuable in global health initiatives. With a strong focus on innovation, PharmaJet has positioned itself as a leader in the market, contributing to improved vaccination rates and patient comfort. Notable achievements include partnerships with various health organisations, underscoring its commitment to advancing public health through cutting-edge technology.

DitchCarbon Score

How does PharmaJet, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

17

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

27

Industry Benchmark

PharmaJet, Inc.'s score of 17 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

PharmaJet, Inc.'s reported carbon emissions

PharmaJet, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that PharmaJet may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, it will be essential for PharmaJet to consider developing and communicating its climate commitments to align with broader environmental goals.

How Carbon Intensive is PharmaJet, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. PharmaJet, Inc.'s primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is PharmaJet, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for PharmaJet, Inc. is in US, which has a low grid carbon intensity relative to other regions.

PharmaJet, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

PharmaJet, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare PharmaJet, Inc.'s Emissions with Industry Peers

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 1 hour ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Penjet Corporation

US
Updated 27 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated less than a minute ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy